In a recent survey study by Wang and colleagues , a total of 2000 self-administered questionnaires were sent to female obstetricians-gynecologists (ob-gyns) attending the Gynecological Endocrinology workshops held from February to May 2013 in 15 provinces and cities in China. A total of 904 eligible questionnaires were collected (response rate, 45.2%). The majority of the responders knew that hormone therapy (HT) could relieve menopausal symptoms (97.7%) and prevent osteoporosis (93.5%). Most (69.4%) of the responders thought that HT would increase the risk of breast cancer, and 52.9% thought that HT would increase the risk of endometrial cancer. The most common concern about the side-effects of HT was the risk of breast cancer, followed by risks of endometrial cancer, venous thrombosis and weight gain. A total of 123 of the 324 symptomatic responders (38.0%) reported HT use, and a further 28 (8.6%) had tried transdermal and vaginal estrogen cream.
Beijing Obstetrics & Gynecology Hospital, Capital Medical University, Beijing, China
Wang Y, Yang X, Li X, et al. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey. Menopause 2014 Apr 14. Epub ahead of print
de Villiers TJ, Gass ML, Haines CJ, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013;16:203-4
Deng XH, Zhang SW. The epidemiological survey of perimenopausal women in Beijing. Beijing Medicine 2002;24(4):235-8 [published in Chinese]
Yang D, Haines CJ, Pan P, et al. Menopausal symptoms in mid-life women in southern China. Climacteric 2008;11:329-36
Lam PM, Leung TN, Haines C, et al. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 4060 years. Maturitas 2003;45:99-107
Huang KE, Xu L, I NN, Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 2010;65:276-83